Plunkett Research Online: Virbac SA

VIRBAC SA (VRBCF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America......



Virbac SA
Ticker: VRBCF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 33 492087100
Fax: 33 492087165
Address: 2065m LID
1 ere avenue
Carros, 06516 France

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
Veterinary Pharmaceuticals
Product Development
Product Manufacturing
Contacts Description
Marie-Helene Dick-MadelpuechChairman of the Board/Director
Solene MadelpuechDirector
See More
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America......See More See More

Auditor: Novances-David & Associes
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202320222021202020192018
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Fr3sh Technology
Cyclavance
Deltanil
Effitix
Neoprinil
Pronefra
Milpro
CET OraStrip
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: